• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以癌胚抗原(CEA)初始升高为表现的甲状腺髓样癌。

Medullary thyroid carcinoma presenting with an initial CEA elevation.

作者信息

Abraham Deepak, Delbridge Leigh, Clifton-Bligh Roderick, Clifton-Bligh Phillip, Grodski Simon, Robinson Bruce G, Messina Marinella, Sidhu Stan

机构信息

University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, St. Leonard's 2065 NSW, Australia.

出版信息

ANZ J Surg. 2010 Nov;80(11):831-3. doi: 10.1111/j.1445-2197.2010.05350.x.

DOI:10.1111/j.1445-2197.2010.05350.x
PMID:20969693
Abstract

BACKGROUND

Carcinoembryonic antigen (CEA) is a tumour marker commonly associated with gastrointestinal malignancy. Patients presenting with an elevated CEA will therefore often undergo extensive investigations in order to elucidate an underlying gastrointestinal malignancy that may not be clinically apparent. However the GI tract is not the only source of CEA elevation.

METHODS

We present a series of patients presenting with raised CEA levels that were initially investigated for a gastrointestinal cause, but after work up were detected to have medullary thyroid cancer.

RESULTS

Four patients with raised CEA were evaluated for a gastrointestinal cause for the elevation. We discuss the non gastrointestinal causes for an elevated CEA.

CONCLUSION

The paper highlights that in patients presenting with an elevated CEA, in whom a gastrointestinal cause has been ruled out, a tumour of neuroendocrine origin needs to be considered as a cause for the elevated CEA.

摘要

背景

癌胚抗原(CEA)是一种通常与胃肠道恶性肿瘤相关的肿瘤标志物。因此,癌胚抗原水平升高的患者常常会接受广泛的检查,以查明可能在临床上并不明显的潜在胃肠道恶性肿瘤。然而,胃肠道并非导致癌胚抗原升高的唯一原因。

方法

我们报告了一系列癌胚抗原水平升高的患者,这些患者最初因胃肠道病因接受检查,但检查后被诊断为甲状腺髓样癌。

结果

对4例癌胚抗原升高的患者进行了胃肠道病因评估。我们讨论了癌胚抗原升高的非胃肠道病因。

结论

本文强调,对于癌胚抗原升高且已排除胃肠道病因的患者,需考虑神经内分泌起源的肿瘤作为癌胚抗原升高的原因。

相似文献

1
Medullary thyroid carcinoma presenting with an initial CEA elevation.以癌胚抗原(CEA)初始升高为表现的甲状腺髓样癌。
ANZ J Surg. 2010 Nov;80(11):831-3. doi: 10.1111/j.1445-2197.2010.05350.x.
2
[Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].[血清降钙素、癌胚抗原和甲胎蛋白检测在甲状腺髓样癌复发早期诊断中的应用价值]
Wiad Lek. 2002;55(7-8):394-403.
3
Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.癌胚抗原水平异常与甲状腺髓样癌进展:一项多变量分析
Arch Surg. 2007 Mar;142(3):289-93; discussion 294. doi: 10.1001/archsurg.142.3.289.
4
[The routine immunohistochemical diagnosis and surgical treatment of medullary carcinoma of the thyroid].[甲状腺髓样癌的常规免疫组化诊断及外科治疗]
Khirurgiia (Sofiia). 1995;48(2):17-9.
5
Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.通过逆转录聚合酶链反应检测循环降钙素和癌胚抗原mRNA作为甲状腺髓样癌的肿瘤标志物
Br J Cancer. 2001 Nov 16;85(10):1546-50. doi: 10.1054/bjoc.2001.2111.
6
[Role of markers in the diagnosis and follow-up of thyroid carcinomas].
Chir Ital. 1994;46(4):42-5.
7
Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.胰腺、前列腺和甲状腺髓样癌随访期间的血清胆囊收缩素和神经降压素
Anticancer Res. 1999 Mar-Apr;19(2B):1445-50.
8
Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?嗜铬粒蛋白A:甲状腺髓样癌术后复发和转移的另一种肿瘤标志物?
Anticancer Res. 2000 Nov-Dec;20(6D):5257-60.
9
Diagnostic value of serum tumor markers in asymptomatic individuals.血清肿瘤标志物在无症状个体中的诊断价值。
J BUON. 2009 Oct-Dec;14(4):707-10.
10
[A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
Nihon Geka Gakkai Zasshi. 2003 Jun;104(6):488-90.

引用本文的文献

1
Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients.甲状腺髓样癌患者的长期随访
Recent Results Cancer Res. 2025;223:267-291. doi: 10.1007/978-3-031-80396-3_11.
2
Histopathology of C Cells and Medullary Thyroid Carcinoma.C细胞与甲状腺髓样癌的组织病理学
Recent Results Cancer Res. 2025;223:9-50. doi: 10.1007/978-3-031-80396-3_2.
3
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin.基于癌胚抗原和降钙素变化的甲状腺髓样癌的管理。
Front Endocrinol (Lausanne). 2024 Oct 10;15:1418657. doi: 10.3389/fendo.2024.1418657. eCollection 2024.
4
Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms.免疫组织化学在甲状腺肿瘤的病理诊断和治疗中的应用。
Front Endocrinol (Lausanne). 2023 May 31;14:1198099. doi: 10.3389/fendo.2023.1198099. eCollection 2023.
5
A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC).《论测量髓样甲状腺癌(MTC)患者术前和术后癌胚抗原(CEA)值的意义》述评。
Medicina (Kaunas). 2021 Jun 11;57(6):609. doi: 10.3390/medicina57060609.